Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Geron (GERN) Research & Development (2016 - 2025)

Geron (GERN) has disclosed Research & Development for 16 consecutive years, with $13.5 million as the latest value for Q4 2025.

  • Quarterly Research & Development fell 42.18% to $13.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $71.4 million through Dec 2025, down 31.14% year-over-year, with the annual reading at $71.4 million for FY2025, 31.14% down from the prior year.
  • Research & Development hit $13.5 million in Q4 2025 for Geron, down from $21.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $35.5 million in Q2 2023 to a low of $13.5 million in Q4 2025.
  • Historically, Research & Development has averaged $24.1 million across 5 years, with a median of $22.8 million in 2022.
  • Biggest five-year swings in Research & Development: soared 102.28% in 2021 and later crashed 48.67% in 2025.
  • Year by year, Research & Development stood at $24.2 million in 2021, then rose by 16.81% to $28.2 million in 2022, then grew by 16.66% to $32.9 million in 2023, then dropped by 28.8% to $23.4 million in 2024, then plummeted by 42.18% to $13.5 million in 2025.
  • Business Quant data shows Research & Development for GERN at $13.5 million in Q4 2025, $21.1 million in Q3 2025, and $21.7 million in Q2 2025.